病例报告：Ⅰ型麻风反应老年患者高钙血症。
Case Report: Hypercalcemia in an Older Patient with Type I Lepra Reaction.
出版信息
Am J Trop Med Hyg. 2020 Oct;103(4):1439-1440. doi: 10.4269/ajtmh.20-0114.
Abstract
Leprosy is a rare, chronic granulomatous disease, and India accounts for two-thirds of the new cases reported worldwide. Hypercalcemia is a rare complication of granulomatous disease. Here, we report a case of an older adult patient with leprosy and type I lepra reaction presenting with severe hypercalcemia.
摘要
麻风病是一种罕见的慢性肉芽肿性疾病，全球报告的新发病例中，印度占三分之二。高钙血症是一种罕见的肉芽肿性疾病并发症。在这里，我们报告了一例老年麻风病患者，伴 1 型麻风反应，表现为严重高钙血症。
相似文献
1
Case Report: Hypercalcemia in an Older Patient with Type I Lepra Reaction.
Am J Trop Med Hyg. 2020 Oct;103(4):1439-1440. doi: 10.4269/ajtmh.20-0114.
2
Two atypical presentations of lepra reactions.
Int J Mycobacteriol. 2018 Oct-Dec;7(4):390-393. doi: 10.4103/ijmy.ijmy_105_18.
3
Anabolic steroid as an adjuvant in the treatment of chronic lepra reaction and ENL under corticosteroid therapy.
Lepr Rev. 1977 Sep;48(3):181-4. doi: 10.5935/0305-7518.19770023.
4
Cutaneous ulceration as a presenting feature of type 1 lepra reaction: A case report.
Trop Doct. 2022 Apr;52(2):354-356. doi: 10.1177/00494755211068661. Epub 2022 Jan 10.
5
A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine.
Int J Mycobacteriol. 2021 Oct-Dec;10(4):472-474. doi: 10.4103/ijmy.ijmy_164_21.
6
Lepromatous leprosy in Saudi female from central region.
J Hyg Epidemiol Microbiol Immunol. 1991;35(2):163-6.
7
Rare atypical presentations in Type 2 lepra reaction: a case series.
Int J Dermatol. 2014 Mar;53(3):323-6. doi: 10.1111/ijd.12292. Epub 2013 Oct 18.
8
Type 1 (reversal) lepra reaction in borderline leprosy with unusual clinical presentation--a case report.
Indian J Lepr. 1987 Apr-Jun;59(2):219-22.
9
A dissimulate presentation of histoid Hansen's disease in the form of erythema nodosum leprosum.
Int J Mycobacteriol. 2019 Apr-Jun;8(2):208-210. doi: 10.4103/ijmy.ijmy_43_19.
10
Comparison of colchicine and aspirin in the treatment of type 2 lepra reaction.
Lepr Rev. 1988 Sep;59(3):201-3. doi: 10.5935/0305-7518.19880025.
本文引用的文献
1
Hypercalcemia secondary to leprosy.
Am J Med Sci. 2004 Dec;328(6):357-9. doi: 10.1016/s0002-9629(15)33948-3.
2
Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment.
Infect Immun. 2001 May;69(5):3413-7. doi: 10.1128/IAI.69.5.3413-3417.2001.
3
Hypercalcemia in granulomatous disorders: a clinical review.
Curr Opin Pulm Med. 2000 Sep;6(5):442-7. doi: 10.1097/00063198-200009000-00010.
4
Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids.
Science. 1995 Oct 13;270(5234):283-6. doi: 10.1126/science.270.5234.283.
5
Hypercalcemia in leprosy.
Arch Intern Med. 1985 Jul;145(7):1305-6.
6
Leprosy, hypercalcemia, and elevated serum calcitriol levels.
Ann Intern Med. 1986 Dec;105(6):890-1. doi: 10.7326/0003-4819-105-6-890.
7
Hypercalcemia and abnormal 1,25-dihydroxyvitamin D concentrations in leprosy.
Am J Med. 1988 Feb;84(2):325-9. doi: 10.1016/0002-9343(88)90434-2.
Zotero 插件